Shanghai Pulmonary Hospital
A lung-only hospital in Shanghai with one of the largest thoracic surgery volumes anywhere and a medical oncology group that has led many Chinese lung cancer trials.
Shanghai Pulmonary Hospital, affiliated to Tongji University, is a national clinical research centre for lung disease and a very high-volume thoracic surgery centre, known for uniportal and robotic lobectomy and for large early-stage screening cohorts. Caicun Zhou's Department of Medical Oncology has been the Chinese lead site for first-generation EGFR inhibitor trials, camrelizumab, sintilimab and tislelizumab combinations, and ADC studies in NSCLC. The hospital publishes extensively on ground-glass nodules, minimally invasive surgery and the molecular epidemiology of lung cancer in never-smokers.
- Lung cancer medical oncology trials
- Thoracic surgery
- Lung nodule management
Pages like this
not linked directly; found by shared links- ProductEnsartinib
Shares ALK, Small-molecule kinase inhibitors, Non-small-cell lung cancer.
- InstitutionShanghai Chest Hospital
Shares ALK, Robotic & minimally invasive surgery, Small-cell lung cancer, EGFR.
- TrialHARMONi-2
Shares Caicun Zhou, PD-1, Non-small-cell lung cancer.
- ProductCeritinib
Shares ALK, Small-molecule kinase inhibitors, Non-small-cell lung cancer.
- ProductBrigatinib
Shares ALK, Small-molecule kinase inhibitors, Non-small-cell lung cancer.
- InstitutionGuangdong Provincial People's Hospital
Shares ALK, EGFR, PD-1, Small-molecule kinase inhibitors.
- ProductDacomitinib
Shares EGFR, Small-molecule kinase inhibitors, Non-small-cell lung cancer.
- TechnologyRobotic and navigational bronchoscopy
Shares CT (computed tomography), Robotic & minimally invasive surgery, Non-small-cell lung cancer.